Stevens Johnson Syndrome
Every year approximately 33,000 people worldwide are stricken with Stevens Johnson Syndrome (SJS), including 1,500 in the United States.
SJS and a more severe variant of the disease, toxic epidermal necrolysis syndrome (TENS), are caused by intense immune reactions to medication or infection. SJS and TENS cause severe blistering of the skin and mucous membranes, including the eyes.
For as many as 5% of those with SJS and 40% with TENS, the syndrome is fatal.
SJS can permanently damage the inside of the eyelids, causing the lid edges to become rough and develop abnormal fine lashes that rub against the cornea. SJS also damages tear, mucous, and oil glands that are critical to maintaining a healthy ocular surface. SJS can lead to extreme pain and light sensitivity, and scarring resulting in blindness.
Currently there is no cure for the damage to the eyes caused by SJS. But PROSE treatment can provide relief and improved vision for patients.
Learn more at the Stevens Johnson Syndrome Foundation.
100% of patients with ocular complications from SJS / TENS reported that their eye health, vision, and quality of life improved with PROSE treatment by BostonSight.
Figures are based on respondents to a 2024 BostonSight survey of 2000 PROSE patients.